Filing Details
- Accession Number:
- 0001562180-17-001461
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-04-04 21:41:17
- Reporting Period:
- 2017-03-31
- Filing Date:
- 2017-04-04
- Accepted Time:
- 2017-04-04 21:41:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100412 | Array Biopharma Inc | ARRY | Pharmaceutical Preparations (2834) | 841460811 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1191818 | Kyle Lefkoff | C/O Boulder Ventures 1941 Pearl Street, Suite 300 Boulder CO 80302 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2016-11-28 | 2,000 | $0.00 | 6,585 | No | 5 | G | Direct | |
| Common Stock | Acquisiton | 2017-03-31 | 25,000 | $3.69 | 31,585 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-03-31 | 20,000 | $4.36 | 51,585 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-03-31 | 45,000 | $8.92 | 6,585 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2017-03-31 | 25,000 | $0.00 | 25,000 | $3.69 |
| Common Stock | Stock Option | Disposition | 2017-03-31 | 20,000 | $0.00 | 20,000 | $4.36 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-04-25 | No | 4 | M | Direct | |
| 0 | 2013-10-24 | 2022-10-24 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 45,000 | Indirect | See footnote |
Footnotes
- The price reported for these shares is the weighted average sale price. Details of actual prices for shares sold are available from the Issuer upon request.
- Comprised of 30,000 shares of common stock in trust for the benefit of Mr. Lefkoff's minor children and 15,000 shares of common stock held by BV Partners III Profit Sharing account for the benefit of Mr. Lefkoff.
- The option vested in 2 equal annual installments beginning on April 25, 2013.
Billionaire Hedge Funds
